TACE + Sorafenib May Change Standard in HCC - If Overall Survival Data is Positive then Standard of Care Will Change - 101967

Spotlight
Video

TACE + Sorafenib May Change Standard in HCC - If Overall Survival Data is Positive then Standard of Care Will Change

Loading........
Description: Masatoshi Kudo, MD from Kindai University, Japan discusses TACE + Sorafenib may change standard in HCC and if overall survival data is positive then standard of care will change at the 2018 Gastrointestinal Cancers Symposium.
Shared By : Gastrointestinal-Cancer-Meeting
Posted on : 01/26/18
Added : 3 months ago